id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
inlawrev-21522	Holman, Christopher M.	In Defense of Secondary Pharmaceutical Patents: A Response to the UN's Guidelines for Pharmaceutical Patent Examination	2017	53	.pdf	application/pdf	24104	1287	53	Courts in Austria62 and Germany ruled similarly, with the Austrian court noting the unexpected and surprisingly high effectiveness of olanzapine compared with prior art drugs, including: (1) potential suitability as a neuroleptic, even in small doses; (2) no extrapyramidal side-effects; (3) no agranulocytosis; and (4) fewer instances of elevated liver enzymes. The Working Paper came out25 strongly against such patent claims, recommending that M arkush claims “covering a large range of compounds should not be allowed.”	cache/inlawrev-21522.pdf	txt/inlawrev-21522.txt